サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1546151

呼吸器診断の世界市場

Respiratory Diagnostics

出版日
ページ情報
英文 174 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
呼吸器診断の世界市場
出版日: 2024年09月03日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 174 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

呼吸器診断の世界市場は2030年までに98億米ドルに達する見込み

2023年に72億米ドルと推定される呼吸器診断の世界市場は、2023年から2030年にかけてCAGR 4.5%で成長し、2030年には98億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである機械検査は、CAGR 4.6%を記録し、分析期間終了時には58億米ドルに達すると予測されます。画像検査分野の成長率は、分析期間中CAGR 5.1％と推定されます。

米国市場は推定20億米ドル、中国はCAGR7.5%で成長予測

米国の呼吸器診断市場は2023年に20億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに21億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは7.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.3％と3.7％と予測されています。欧州では、ドイツがCAGR 2.9%で成長すると予測されています。

世界の呼吸器診断市場- 主要動向と促進要因まとめ

呼吸器診断：肺疾患の検出を進める

呼吸器診断は、より正確で非侵襲的かつ迅速な検査法を提供することで、肺疾患の検出と管理に革命をもたらしています。これらの診断法には、スパイロメトリー、血液ガス分析、画像技術を含む様々な検査が含まれ、肺機能を評価し、結核、喘息、慢性閉塞性肺疾患（COPD）、肺感染症などの状態を検出します。呼吸器疾患の多くは放置すると重篤な合併症を引き起こす可能性があるため、効果的な治療と管理を行うためには早期発見が極めて重要です。診断技術の進歩により、ヘルスケアプロバイダーは呼吸器疾患をより正確に診断できるようになり、患者の転帰の改善と罹患者の生活の質の向上につながります。

どのような技術の進歩が呼吸器診断を向上させているか？

技術の進歩は、呼吸器診断の機能を大幅に向上させ、より正確で、よりアクセスしやすく、より使いやすくしています。高解像度コンピュータ断層撮影法（HRCT）や磁気共鳴画像法（MRI）などの画像技術の革新は、肺の構造を詳細に可視化することを可能にし、標準的なX線ではわからないような病気の早期発見を可能にします。さらに、ハンドヘルド・スパイロメーターやパルスオキシメーターなどのポータブル・ポイントオブケア診断機器の開発により、ヘルスケアプロバイダーはプライマリケアオフィスや患者の自宅など、さまざまな環境での検査が容易になった。ポリメラーゼ連鎖反応（PCR）や次世代シークエンシング（NGS）を含む分子診断学の進歩により、呼吸器疾患に関連する特定の病原体や遺伝子マーカーの検出能力も向上しています。このような技術革新が呼吸器診断の採用を後押しし、肺の健康状態をより包括的かつ正確に評価できるようになっています。

呼吸器診断の主な用途と利点は？

呼吸器診断は、肺機能の評価、呼吸器疾患の診断、治療効果のモニタリングなど、幅広い臨床現場で使用されています。プライマリーケアでは、スパイロメトリーは肺活量と気流を測定する一般的な診断ツールであり、喘息やCOPDなどの疾患の診断に役立ちます。病院では、血液ガス分析やHRCTスキャンなどのより高度な検査が、呼吸器疾患の重症度の評価や治療方針の決定に用いられています。呼吸器検査における分子診断学の使用は、特に呼吸器感染症の原因となる特定の病原体を特定し、的を絞った治療を可能にする上で、ますます重要になってきています。呼吸器診断の主な利点は、肺疾患の早期発見、診断精度の向上、疾患の進行や治療成績のモニタリングの向上などです。これらの利点により、呼吸器診断はより良い患者ケアと疾病管理をサポートする、現代のヘルスケアに不可欠な要素となっています。

呼吸器診断市場の成長を促進する要因は？

呼吸器診断市場の成長は、いくつかの要因によって牽引されています。喘息、COPD、肺感染症などの呼吸器系疾患の有病率の増加は重要な促進要因であり、これらの疾患は正確で信頼性の高い診断ツールに対する需要の高まりを生み出しています。特に画像診断、分子診断、ポイントオブケア機器などの技術的進歩も、呼吸器診断の機能とアクセシビリティを高めることで市場の成長を後押ししています。呼吸器疾患の早期発見・早期管理の重要性に対する意識の高まりは、早期介入によって合併症を予防し、患者の転帰を改善できることから、これらの診断薬に対する需要をさらに押し上げています。さらに、COVID-19パンデミックの継続的な影響は、効果的な呼吸器診断の必要性を浮き彫りにし、この分野へのさらなる投資と技術革新を促しています。これらの要因が、医療技術の継続的な進歩と相まって、呼吸器診断市場の持続的成長を後押ししています。

調査対象企業の例（注目の43社）

  • Abbott Laboratories
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cosmed Srl
  • Philips Healthcare
  • SDI Diagnostics
  • Seegene, Inc.
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP14425

Global Respiratory Diagnostics Market to Reach US$9.8 Billion by 2030

The global market for Respiratory Diagnostics estimated at US$7.2 Billion in the year 2023, is expected to reach US$9.8 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Mechanical Tests, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Imaging Tests segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 7.5% CAGR

The Respiratory Diagnostics market in the U.S. is estimated at US$2.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Respiratory Diagnostics Market - Key Trends and Drivers Summarized

Respiratory Diagnostics: Advancing the Detection of Lung Diseases

Respiratory diagnostics are revolutionizing the detection and management of lung diseases by providing more accurate, non-invasive, and rapid testing methods. These diagnostics encompass a range of tests, including spirometry, blood gas analysis, and imaging techniques, that assess lung function and detect conditions such as tuberculosis, asthma, chronic obstructive pulmonary disease (COPD), and lung infections. Early detection of respiratory diseases is crucial for effective treatment and management, as many of these conditions can lead to severe complications if left untreated. With advancements in diagnostic technology, healthcare providers can now diagnose respiratory conditions with greater precision, leading to improved patient outcomes and a higher quality of life for those affected.

What Technological Advancements Are Enhancing Respiratory Diagnostics?

Technological advancements are significantly enhancing the capabilities of respiratory diagnostics, making them more accurate, accessible, and user-friendly. Innovations in imaging technology, such as high-resolution computed tomography (HRCT) and magnetic resonance imaging (MRI), allow for detailed visualization of lung structures, enabling the early detection of diseases that may not be apparent on standard X-rays. Additionally, the development of portable and point-of-care diagnostic devices, such as handheld spirometers and pulse oximeters, has made it easier for healthcare providers to conduct tests in various settings, including primary care offices and patient homes. Advances in molecular diagnostics, including polymerase chain reaction (PCR) and next-generation sequencing (NGS), have also improved the ability to detect specific pathogens and genetic markers associated with respiratory diseases. These technological innovations are driving the adoption of respiratory diagnostics, providing more comprehensive and accurate assessments of lung health.

What Are the Key Applications and Benefits of Respiratory Diagnostics?

Respiratory diagnostics are used in a wide range of clinical settings to assess lung function, diagnose respiratory diseases, and monitor treatment effectiveness. In primary care, spirometry is a common diagnostic tool used to measure lung capacity and airflow, helping to diagnose conditions like asthma and COPD. In hospitals, more advanced tests such as blood gas analysis and HRCT scans are used to assess the severity of respiratory conditions and guide treatment decisions. The use of molecular diagnostics in respiratory testing has become increasingly important, particularly in identifying the specific pathogens causing respiratory infections, enabling targeted treatment. The primary benefits of respiratory diagnostics include early detection of lung diseases, improved accuracy in diagnosis, and better monitoring of disease progression and treatment outcomes. These advantages make respiratory diagnostics a critical component of modern healthcare, supporting better patient care and disease management.

What Factors Are Driving the Growth in the Respiratory Diagnostics Market?

The growth in the Respiratory Diagnostics market is driven by several factors. The increasing prevalence of respiratory diseases, such as asthma, COPD, and lung infections, is a significant driver, as these conditions create a growing demand for accurate and reliable diagnostic tools. Technological advancements, particularly in imaging, molecular diagnostics, and point-of-care devices, are also propelling market growth by enhancing the capabilities and accessibility of respiratory diagnostics. The rising awareness of the importance of early detection and management of respiratory conditions is further boosting demand for these diagnostics, as early intervention can prevent complications and improve patient outcomes. Additionally, the ongoing impact of the COVID-19 pandemic has highlighted the critical need for effective respiratory diagnostics, driving further investment and innovation in this field. These factors, combined with the continuous advancement of medical technology, are driving the sustained growth of the Respiratory Diagnostics market.

Select Competitors (Total 43 Featured) -

  • Abbott Laboratories
  • Alere, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cosmed Srl
  • Philips Healthcare
  • SDI Diagnostics
  • Seegene, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Respiratory Diagnostics: Overview & Outlook
    • Respiratory Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Mounting Burden of Respiratory Diseases: Major Driver
    • Pulmonary Function Test: Major Category
    • Imaging Tests Gain Traction
    • CT Screening for Improved Pulmonary Pathology
    • Bronchoscopy & Laryngoscopy for Evaluating the Airway Directly
    • Rising Cost of Medical Treatment Deters Growth
    • Rising Prevalence of Respiratory Diseases Propels Market Growth
    • Increasing Use of Diagnostic Tests in Early Detection and Disease Management Expands Addressable Market Opportunity
    • Technological Advancements in Imaging and Molecular Diagnostics Strengthen Market Position
    • Growing Focus on Personalized Medicine and Targeted Therapies Drives Adoption of Respiratory Diagnostics
    • Surge in Demand for Point-of-Care and Rapid Testing Solutions Generates New Opportunities
    • Development of Non-Invasive and Minimally Invasive Diagnostic Tools Sustains Market Growth
    • Expanding Applications in Chronic Obstructive Pulmonary Disease (COPD) and Asthma Throws Spotlight on Market Potential
    • Rising Adoption of Respiratory Diagnostics in Homecare Settings Propels Market Expansion
    • Surge in Demand for Diagnostic Solutions Amidst Global Respiratory Disease Outbreaks Expands Market Horizons
    • Growing Awareness of the Importance of Early Diagnosis in Improving Patient Outcomes Drives Market Adoption
    • Innovations in Artificial Intelligence and Machine Learning for Diagnostic Accuracy Generate New Market Opportunities
    • Rising Demand for Respiratory Diagnostics in Emerging Healthcare Markets Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Tuberculosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Tuberculosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Tuberculosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Chronic Obstructive Pulmonary Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Chronic Obstructive Pulmonary Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Chronic Obstructive Pulmonary Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Instruments & Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Instruments & Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Instruments & Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Services & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Services & Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Services & Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Mechanical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Mechanical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Mechanical Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Imaging Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Imaging Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Imaging Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Molecular Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Molecular Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Molecular Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Other Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 34: World Respiratory Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Respiratory Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • JAPAN
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • CHINA
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • EUROPE
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Respiratory Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • GERMANY
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Respiratory Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • INDIA
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: India 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Respiratory Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Respiratory Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Respiratory Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030
  • AFRICA
    • Respiratory Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Respiratory Diagnostics by Disease - Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Respiratory Diagnostics by Disease - Percentage Breakdown of Value Sales for Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease and Other Diseases for the Years 2014, 2024 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Respiratory Diagnostics by Offering - Instruments & Devices, Kits & Reagents and Services & Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Respiratory Diagnostics by Offering - Percentage Breakdown of Value Sales for Instruments & Devices, Kits & Reagents and Services & Software for the Years 2014, 2024 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Respiratory Diagnostics by Test - Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Respiratory Diagnostics by Test - Percentage Breakdown of Value Sales for Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests and Other Tests for the Years 2014, 2024 & 2030

IV. COMPETITION